StockData
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. (SCNI) stock

SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.37−0.03 (-7.82%)

Close on Nov 17, 2026Market cap $1.29MP/E –Yield –

Scinai Immunotherapeutics ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was -$6.12M. The highest annual figure on record is -$6.12M in fiscal 2025.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$6.12M–
FY2024Dec 31, 2024-$6.99M–
FY2023Dec 31, 2023-$9.19M–
FY2022Dec 31, 2022-$10.50M–
FY2021Dec 31, 2021-$10.39M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2023Jun 30, 2023-$2.45M–
Q1 FY2023Mar 31, 2023-$3.05M–
Q2 FY2022Jun 30, 2022-$3.12M–
Q1 FY2022Mar 31, 2022-$2.48M–

More Scinai Immunotherapeutics figures

See a number that looks wrong?